273 related articles for article (PubMed ID: 18196260)
1. Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma.
Helin M; Rönkkö S; Puustjärvi T; Teräsvirta M; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):739-46. PubMed ID: 18196260
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.
Rönkkö S; Rekonen P; Kaarniranta K; Puustjarvi T; Teräsvirta M; Uusitalo H
Mol Vis; 2007 Mar; 13():408-17. PubMed ID: 17417602
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients.
Helin-Toiviainen M; Rönkkö S; Puustjärvi T; Rekonen P; Ollikainen M; Uusitalo H
Acta Ophthalmol; 2015 Mar; 93(2):165-71. PubMed ID: 25312247
[TBL] [Abstract][Full Text] [Related]
4. A novel role of group VIB calcium-independent phospholipase A2 (iPLA2gamma) in the inducible expression of group IIA secretory PLA2 in rat fibroblastic cells.
Kuwata H; Fujimoto C; Yoda E; Shimbara S; Nakatani Y; Hara S; Murakami M; Kudo I
J Biol Chem; 2007 Jul; 282(28):20124-32. PubMed ID: 17475622
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival inflammatory cells and their predictive role for deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma.
Helin M; Rönkkö S; Puustjärvi T; Teräsvirta M; Ollikainen M; Uusitalo H
J Glaucoma; 2011 Mar; 20(3):172-8. PubMed ID: 20577105
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of phospholipases A2 in neuronal death and neurogenesis: implications for Alzheimer disease.
Schaeffer EL; da Silva ER; Novaes Bde A; Skaf HD; Gattaz WF
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1381-9. PubMed ID: 20804810
[TBL] [Abstract][Full Text] [Related]
7. Localization and functional interrelationships among cytosolic Group IV, secreted Group V, and Ca2+-independent Group VI phospholipase A2s in P388D1 macrophages using GFP/RFP constructs.
Shirai Y; Balsinde J; Dennis EA
Biochim Biophys Acta; 2005 Jul; 1735(2):119-29. PubMed ID: 15967714
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase A2 superfamily members play divergent roles after spinal cord injury.
López-Vales R; Ghasemlou N; Redensek A; Kerr BJ; Barbayianni E; Antonopoulou G; Baskakis C; Rathore KI; Constantinou-Kokotou V; Stephens D; Shimizu T; Dennis EA; Kokotos G; David S
FASEB J; 2011 Dec; 25(12):4240-52. PubMed ID: 21868473
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma.
Rönkkö S; Rekonen P; Kaarniranta K; Puustjärvi T; Teräsvirta M; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):697-704. PubMed ID: 17028863
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients.
Helin-Toiviainen M; Rönkkö S; Kaarniranta K; Puustjärvi T; Rekonen P; Ollikainen M; Uusitalo H
Acta Ophthalmol; 2017 Jun; 95(4):378-385. PubMed ID: 28139882
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
Ollikainen M; Puustjärvi T; Rekonen P; Uusitalo H; Teräsvirta M
Acta Ophthalmol; 2010 Feb; 88(1):20-6. PubMed ID: 19432842
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Ollikainen ML; Puustjärvi TJ; Rekonen PK; Uusitalo HM; Teräsvirta ME
Acta Ophthalmol; 2011 Sep; 89(6):548-55. PubMed ID: 19925527
[TBL] [Abstract][Full Text] [Related]
13. Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma.
Rekonen P; Kannisto T; Puustjärvi T; Teräsvirta M; Uusitalo H
Acta Ophthalmol Scand; 2006 Aug; 84(4):507-11. PubMed ID: 16879572
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 biochemistry.
Burke JE; Dennis EA
Cardiovasc Drugs Ther; 2009 Feb; 23(1):49-59. PubMed ID: 18931897
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic action of secreted phospholipase A2 in prostate cancer.
Sved P; Scott KF; McLeod D; King NJ; Singh J; Tsatralis T; Nikolov B; Boulas J; Nallan L; Gelb MH; Sajinovic M; Graham GG; Russell PJ; Dong Q
Cancer Res; 2004 Oct; 64(19):6934-40. PubMed ID: 15466184
[TBL] [Abstract][Full Text] [Related]
16. Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury.
Yano T; Fujioka D; Saito Y; Kobayashi T; Nakamura T; Obata JE; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Tamaru S; Kugiyama K
Cardiovasc Res; 2011 May; 90(2):335-43. PubMed ID: 21169294
[TBL] [Abstract][Full Text] [Related]
17. Differential behavior of sPLA2-V and sPLA2-X in human neutrophils.
Solodkin-Szaingurten I; Levy R; Hadad N
Biochim Biophys Acta; 2007 Feb; 1771(2):155-63. PubMed ID: 17275398
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of cPLA(2) gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific.
Li B; Gu L; Zhang H; Huang J; Chen Y; Hertz L; Peng L
Psychopharmacology (Berl); 2007 Oct; 194(3):333-45. PubMed ID: 17594078
[TBL] [Abstract][Full Text] [Related]
19. Diverse regulation of retinal pigment epithelium phagocytosis of photoreceptor outer segments by calcium-independent phospholipase A₂, group VIA and secretory phospholipase A₂, group IB.
Zhan C; Wang J; Kolko M
Curr Eye Res; 2012 Oct; 37(10):930-40. PubMed ID: 22680611
[TBL] [Abstract][Full Text] [Related]
20. Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2.
Pruzanski W; Lambeau G; Lazdunski M; Cho W; Kopilov J; Kuksis A
Biochim Biophys Acta; 2007 Jan; 1771(1):5-19. PubMed ID: 17197234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
